版本:
中国

BRIEF-Proqr to present QR-010 data at European Cystic Fibrosis Society conference

June 8 Proqr Therapeutics NV:

* Proqr to present QR-010 data at the European Cystic Fibrosis Society conference and provides an update on the ongoing phase 1b trial

* Proqr Therapeutics - cohort 7 is completed in phase 1b study, PQ-010-001, and enrollment of final cohort is expected to be completed in June 2017

* Proqr Therapeutics - topline safety, exploratory efficacy data from multiple dose cohorts in phase 1b trial pq-010-001 expected to be released in Sept 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐